InvestorsHub Logo

chuckanutman

04/25/14 8:23 PM

#65289 RE: MightyLion #65288

GE's Dr. Minger values Advanced Cell Technology ACTC. He is Global Director for Healthcare Life Sciences Research.

farviewhill

04/25/14 11:08 PM

#65290 RE: MightyLion #65288

If you have any thoughts or expertise in he corporate finance areas, what else can you offer or see as the most realistic next corporate steps to address their dire financial situation/structure and lay a sound groundwork to begin and finance phase 11?

I'm far from knowledgeable about corporate finance survival, but anyone can see there's a real serious problem and something drastic has to change. For me it begs the question, why accept a JV or buy in if still viable given their debt baggage, etc., which would come at a huge depreciastion/cost for the company to any potential future commercialization AND still have the upcoming litigation debt to deal with, vs. something like reorganizing the company under chapter 11, restructing/getting rid of the debt and proceeding with new forms of financing, if possible, given their phase 1 promise?
I and I'm sure others, worry about the latter as chapter 11 makes our investment worthless, even though the company survives and reorganizes into a slimmer entity.

Would love and appreciate someone pointing out the flaws in my thoughts or other ways for the company to finance and proceed, which has to make even the Lincoln's of the financing world unwilling partners at this stage, it sees to me?